Koss's cytology of the urinary tract with histopathologic correlations

著者

書誌事項

Koss's cytology of the urinary tract with histopathologic correlations

Leopold G Koss, Rana S. Hoda

Springer, c2012

タイトル別名

Cytology of the urinary tract with histopathologic correlations

大学図書館所蔵 件 / 全2件

この図書・雑誌をさがす

注記

Includes bibliographical references and index

内容説明・目次

内容説明

This new volume fills the gap in the literature as it will guide urologists and pathologists in the proper utilization of a variety of laboratory methods that are currently available to determine the presence, persistence or progression of tumors of the lower urinary tract. The volume emphasizes cytology of the urinary tract which is preferred over other methods (i.e. biochemical, immunological and cytogenetic) for its accuracy, especially for the important high grade tumors. This volume will appeal to urologists as well as pathologists, cytopathologists and related professions. The illustrations, nearly all in color, stress the key points of the text and enhance basic understanding of urothelial and other tumors of the urinary tract.

目次

Chapter 1- Introduction Chapter 2- Indication, Collection and Laboratory Processing of Cytologic Samples Principal Indication Collection Techniques Laboratory Processing of Samples Suggested Reading Chapter 3- The Cellular and Acellular Components of the Urinary Sediment Normal Urothelium (Transitional Epithelium) and Its Cells Other Benign Cells Noncellular Components of the Urinary Sediment Suggested Reading Chapter 4- The Cytologic Makeup of the Urinary Sediment According to the Collection Technique Voided urine Cytologic Makeup of Bladder Washings Cytologic Makeup of Normal Specimens Obtained by Retrograde Catheterization Cytologic Makeup of Smears Obtained by Brushing Cytologic Makeup of Ileal Bladder Urine Chapter 5- Cytologic Manifestations of Benign Disorders Affecting Cells of the Lower Urinary Tract Inflammatory disorders Cellular inclusions not due to viral agents Trematodes and other parasites Lithiasis Leukoplakia Effect of Drugs Effects of radiotherapy Monitoring of renal transplant patients Urinary Cytology in Renal Transplant Patients Rare benign conditions Suggested Reading Chapter 6- Tumors of the Bladder Non-Neoplastic Changes Hyperplasia Inverted papilloma Urothelial (Transitional) Cell Tumors Epidemiology Classification and natural history Types of Urothelial Tumors A. Papillary Urothelial Neoplasms I. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial Carcinoma B. Nonpapillary Urothelial Tumors I. Invasive Urothelial Carcinomas II. Flat Carcinoma In Situ (IUN III): Clinical Presentation, Histology Histologic Variants of Urothelial Carcinoma Metastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary Tract Reporting of cytologic findings Suggested Reading Chapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder Neoplasms Introduction US FDA-approved Markers Potential Markers in Earlier Phases of Clinical Development Markers Detected by Immunocytochemistry Comparison between Urine Cytology and FDA-approved Markers Conclusion References Chapter 4- The Cytologic Makeup of the Urinary Sediment According to the Collection Technique Voided urine Cytologic Makeup of Bladder Washings Cytologic Makeup of Normal Specimens Obtained by Retrograde Catheterization Cytologic Makeup of Smears Obtained by Brushing Cytologic Makeup of Ileal Bladder Urine Chapter 5- Cytologic Manifestations of Benign Disorders Affecting Cells of the Lower Urinary Tract Inflammatory disorders Cellular inclusions not due to viral agents Trematodes and other parasites Lithiasis Leukoplakia Effect of Drugs Effects of radiotherapy Monitoring of renal transplant patients Urinary Cytology in Renal Transplant Patients Rare benign conditions Suggested Reading Chapter 6- Tumors of the Bladder Non-Neoplastic Changes Hyperplasia Inverted papilloma Urothelial (Transitional) Cell Tumors Epidemiology Classification and natural history Types of Urothelial Tumors A. Papillary Urothelial Neoplasms I. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial Carcinoma B. Nonpapillary Urothelial Tumors I. Invasive Urothelial Carcinomas II. Flat Carcinoma In Situ (IUN III): Clinical Presentation, Histology Histologic Variants of Urothelial Carcinoma Metastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary Tract Reporting of cytologic findings Suggested Reading Chapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder Neoplasms Introduction US FDA-approved Markers Potential Markers in Earlier Phases of Clinical Development Markers Detected by Immunocytochemistry Comparison between Urine Cytology and FDA-approved Markers Conclusion References Cellular inclusions not due to viral agents Trematodes and other parasites Lithiasis Leukoplakia Effect of Drugs Effects of radiotherapy Monitoring of renal transplant patients Urinary Cytology in Renal Transplant Patients Rare benign conditions Suggested Reading Chapter 6- Tumors of the Bladder Non-Neoplastic Changes Hyperplasia Inverted papilloma Urothelial (Transitional) Cell Tumors Epidemiology Classification and natural history Types of Urothelial Tumors A. Papillary Urothelial Neoplasms I. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial Carcinoma B. Nonpapillary Urothelial Tumors I. Invasive Urothelial Carcinomas II. Flat Carcinoma In Situ (IUN III): Clinical Presentation, Histology Histologic Variants of Urothelial Carcinoma Metastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary Tract Reporting of cytologic findings Suggested Reading Chapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder Neoplasms Introduction US FDA-approved Markers Potential Markers in Earlier Phases of Clinical Development Markers Detected by Immunocytochemistry Comparison between Urine Cytology and FDA-approved Markers Conclusion References Chapter 4- The Cytologic Makeup of the Urinary Sediment According to the Collection Technique Voided urine Cytologic Makeup of Bladder Washings Cytologic Makeup of Normal Specimens Obtained by Retrograde Catheterization Cytologic Makeup of Smears Obtained by Brushing Cytologic Makeup of Ileal Bladder Urine Chapter 5- Cytologic Manifestations of Benign Disorders Affecting Cells of the Lower Urinary Tract Inflammatory disorders Cellular inclusions not due to viral agents Trematodes and other parasites Lithiasis Leukoplakia Effect of Drugs Effects of radiotherapy Monitoring of renal transplant patients Urinary Cytology in Renal Transplant Patients Rare benign conditions Suggested Reading Chapter 6- Tumors of the Bladder Non-Neoplastic Changes Hyperplasia Inverted papilloma Urothelial (Transitional) Cell Tumors Epidemiology Classification and natural history Types of Urothelial Tumors A. Papillary Urothelial Neoplasms I. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial Carcinoma B. Nonpapillary Urothelial Tumors I. Invasive Urothelial Carcinomas II. Flat Carcinoma In Situ (IUN III): Clinical Presentation, Histology Histologic Variants of Urothelial Carcinoma Metastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary Tract Reporting of cytologic findings Suggested Reading Chapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder Neoplasms Introduction US FDA-approved Markers Potential Markers in Earlier Phases of Clinical Development Markers Detected by Immunocytochemistry Comparison between Urine Cytology and FDA-approved Markers Conclusion References Cellular inclusions not due to viral agents Trematodes and other parasites Lithiasis Leukoplakia Effect of Drugs Effects of radiotherapy Monitoring of renal transplant patients Urinary Cytology in Renal Transplant Patients Rare benign conditions Suggested Reading Chapter 6- Tumors of the Bladder Non-Neoplastic Changes Hyperplasia Inverted papilloma Urothelial (Transitional) Cell Tumors Epidemiology Classification and natural history Types of Urothelial Tumors A. Papillary Urothelial Neoplasms I. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial Carcinoma B. Nonpapillary Urothelial Tumors I. Invasive Urothelial Carcinomas II. Flat Carcinoma In Situ (IUN III): Clinical Presentation, Histology Histologic Variants of Urothelial Carcinoma Metastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary Tract Reporting of cytologic findings Suggested Reading Chapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder Neoplasms Introduction US FDA-approved Markers Potential Markers in Earlier Phases of Clinical Development Markers Detected by Immunocytochemistry Comparison between Urine Cytology and FDA-approved Markers Conclusion References Cellular inclusions not due to viral agents Trematodes and other parasites Lithiasis Leukoplakia Effect of Drugs Effects of radiotherapy Monitoring of renal transplant patients Urinary Cytology in Renal Transplant Patients Rare benign conditions Suggested Reading Chapter 6- Tumors of the Bladder Non-Neoplastic Changes Hyperplasia Inverted papilloma Urothelial (Transitional) Cell Tumors Epidemiology Classification and natural history Types of Urothelial Tumors A. Papillary Urothelial Neoplasms I. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial Carcinoma B. Nonpapillary Urothelial Tumors I. Invasive Urothelial Carcinomas II. Flat Carcinoma In Situ (IUN III): Clinical Presentation, Histology Histologic Variants of Urothelial Carcinoma Metastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary Tract Reporting of cytologic findings Suggested Reading Chapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder Neoplasms Introduction US FDA-approved Markers Potential Markers in Earlier Phases of Clinical Development Markers Detected by Immunocytochemistry Comparison between Urine Cytology and FDA-approved Markers Conclusion References

「Nielsen BookData」 より

詳細情報

ページトップへ